To conduct a systematic re-evaluation of systematic reviews (SR) or Meta-analyses on the efficacy of motor imagery therapy (MIT) in treating post-stroke motor dysfunction. Methods: A computerized search was conducted in domestic and international databases for SR/Meta-analyses on MIT for post-stroke motor dysfunction, with the search period spanning from the establishment of the databases to September 2023. The AMSTAR 2 tool, PRISMA 2020 guidelines, and GRADE system were employed to evaluate the quality of the included studies in terms of literature quality and evidence quality. Results: Ultimately, 11 studies were included. According to the AMSTAR 2 assessment, there were 2 studies of moderate quality (18.18%), 2 studies of low quality (18.18%), and 7 studies of very low quality (63.64%). The PRISMA 2020 guidelines indicated that 3 studies (27.27% ) had relatively complete reporting, while 8 studies (72.73% ) had certain reporting deficiencies. The GRADE evidence grading revealed a total of 49 outcome indicators, among which 2 were of moderate quality (4.08% ), 24 were of low quality (48.98% ), and 23 were of very low quality evidence (63.64% ). Conclusion: MIT contributes to the recovery of limb motor function, balance function, and activities of daily living in post-stroke patients.